Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

    Vincenzo De Sanctis
    e2020006
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.006
    4130
    PDF: 1486
    HTML: 426
  • THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS

    Gehan Lotfy Abdel Hakeem, hoda Abdel kereem Abdel Samei, Ashraf mohamed El Shereif, Ahlam mohamed ismail
    e2015023
    2015-02-17
    https://doi.org/10.4084/mjhid.2015.023
    2083
    PDF: 877
    HTML: 2987
    Untitled: 180
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1040
    PDF: 591
    HTML: 4265
  • VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

    Ashraf Tawfik Soliman
    e2013057
    2013-09-02
    https://doi.org/10.4084/mjhid.2013.057
    2560
    PDF: 1043
    HTML: 2534
  • GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS

    Naouel GUIRAT
    e2018031
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.031
    2669
    PDF: 973
    HTML: 397
    TABLE: 170
    FIGURES: 211
  • Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

    Shahrzad Zonoozi
    e2017004
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.004
    2814
    PDF: 956
    HTML: 1268
  • IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES

    Paolo Cianciulli
    e2009034
    1209
    PDF: 599
    HTML: 2295
  • BETA THALASSEMIA MAJOR IN A DEVELOPING COUNTRY: EPIDEMIOLOGICAL, CLINICAL AND EVOLUTIONARY ASPECT

    Mohamed Bejaoui, Naouel Guirat
    e2013002
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.002
    1547
    PDF: 876
    HTML: 2457
  • PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA

    Monica Sharma, Sanjay Pandey, Ravi Ranjan, Tulika Seth, Renu Saxena
    e2015004
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.004
    2297
    PDF: 1195
    HTML: 4644
    table: 187
    fig 1: 184
    fig 2: 154
  • PREVALENCE OF THALASSEMIA AMONG NEWBORNS: A RE-VISITED AFTER 20 YEARS OF A PREVENTION AND CONTROL PROGRAM IN NORTHEAST THAILAND.

    Goonnapa Fucharoen
    e2018054
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.054
    1708
    PDF: 1042
    HTML: 193
  • ACQUIRED HYPOGONADOTROPIC HYPOGONADISM (AHH) IN THALASSAEMIA MAJOR PATIENTS: AN UNDERDIAGNOSED CONDITION?

    Vincenzo De Sanctis
    e2016001
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.001
    5039
    PDF: 1254
    HTML: 3548
  • CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT

    Athanasios Aessopos, Vasilios Berdoukas
    e2009002
    2009-07-18
    1535
    PDF: 464
    HTML: 1423
  • PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?

    Kalliopi Zachou, Pinelopi Arvaniti, Nikolaos K. Gatselis, Kalliopi Azariadis, Georgia Papadamou, Eirini Rigopoulou, George N. Dalekos
    e2017003
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.003
    2883
    PDF: 939
    HTML: 2050
    Cover letter: 161
  • A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients

    Kanchan Mishra, Avani Shah, Krima Patel, Kanjaksha Ghosh, Sumit Bharadva
    e2020038
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.038
    1259
    PDF: 740
    HTML: 470
  • TRANSIENT ELASTOGRAPHY (TE) IS A USEFUL TOOL FOR ASSESSING THE RESPONSE OF LIVER IRON CHELATION IN SICKLE CELL DISEASE PATIENTS

    SOPHIA DELICOU
    e2018049
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.049
    1469
    PDF: 770
    HTML: 174
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

    Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
    e2009027
    2009-12-26
    1629
    PDF: 700
    HTML: 2902
  • VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF

    sameh samir fahmey, Hassan Naguib, sanna Abdelshafy, rasha Alashry
    e2013044
    2013-06-05
    https://doi.org/10.4084/mjhid.2013.044
    1239
    PDF: 831
    HTML: 1023
    Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 155
  • LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY

    Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis
    e2014025
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.025
    2123
    PDF: 2095
    HTML: 2402
  • IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE

    Raffaella Mariani, Paola Trombini, Matteo Pozzi, Alberto Piperno
    e2009006
    2009-10-27
    1569
    PDF: 626
    HTML: 43874
  • DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA

    Ali Taher
    e2018066
    2018-11-01
    https://doi.org/10.4084/mjhid.2018.066
    2759
    PDF: 1537
    HTML: 216
  • THALASSEMIA AND VENOUS THROMBOEMBOLISM

    Julien Succar, Khaled M. Musallam, Ali T Taher
    e2011025
    2011-05-25
    https://doi.org/10.4084/mjhid.2011.025
    2866
    PDF: 980
    HTML: 4562
  • HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS

    Emanuele Angelucci, Federica Pilo, Clara Targhetta, Martina Pettinau, Cristina Depau, Claudia Cogoni, Sara Usai, Mario Pani, Laura Dessì, Donatella Baronciani
    e2009015
    1351
    PDF: 476
    HTML: 3941
  • ?-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

    Vincenzo De Sanctis
    e2017018
    2017-02-20
    https://doi.org/10.4084/mjhid.2017.018
    10846
    PDF: 4218
    HTML: 4313
  • THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

    Ignazio Majolino
    e2017031
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.031
    2185
    PDF: 968
    HTML: 2066
  • THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS

    FASOLA ATINUKE
    e2022001
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.001
    2162
    PDF: 924
    HTML: 57
  • Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for ?-thalassemia major

    Giuseppe Visani, Paola Picardi, Barbara Guiduccu, Claudio Giardini, Moira Lucesole, Sara Barulli, Teresa Ricciardi, Federica Loscocco, Alessandro Isidori
    e2013029
    2013-04-15
    https://doi.org/10.4084/mjhid.2013.029
    1419
    PDF: 790
    HTML: 1208
  • RECENT INSIGHTS INTO THE POPULATION GENETICS AND DYNAMICS OF THE INHERITED DISORDERS OF HEMOGLOBIN

    David J Weatherall
    e2009022
    2009-12-20
    1017
    PDF: 438
    HTML: 520
  • EFFECT OF CIS ACTING POTENTIAL REGULATORS IN THE ß GLOBIN GENE CLUSTER ON THE PRODUCTION OF HBF IN THALASSEMIA PATIENTS

    Anita Nadkarni
    e2013012
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.012
    1046
    PDF: 577
    HTML: 3299
  • CHARACTERISTICS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN MULTI-TRANSFUSED PATIENTS WITH THALASSEMIA MAJOR. EXPERIENCE OF A SINGLE TERTIARY CENTER.

    Nikolaos Papadopoulos, Dimitrios Kountouras, Katerina Malagari, Maria Tampaki, Maria Theochari, John Koskinas
    e2020013
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.013
    1645
    PDF: 925
    HTML: 206
  • Should every patient with MDS get iron chelation – probably yes.

    Kanjaksha Ghosh, Emanuele Angelucci, Federica Pilo, Kinjalka Ghosh
    e2017055
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.055
    2243
    PDF: 919
    HTML: 356
  • PRENATAL DIAGNOSIS OF ?-THALASSEMIAS AND HEMOGLOBINOPATHIES

    Maria Cristina Rosatelli, Luisella Saba
    e2009011
    2009-11-15
    1155
    PDF: 358
    HTML: 6343
  • Screening and genetic diagnosis of Hemoglobinopathies in Southern and Northern Europe: Two examples

    Antonio Amato, Piero C Giordano
    e2009007
    2009-08-07
    1121
    PDF: 467
    HTML: 1147
    Amato1: 152
    Figure 2 A: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 229
    jdoe, : 236
    Figure 2 b: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 140
  • Transfusion-related acute lung injury (TRALI) in two thalassaemia patients caused by the same multiparous blood donor

    George J Kontoghiorghes
    e2017060
    2017-10-18
    https://doi.org/10.4084/mjhid.2017.060
    1945
    PDF: 627
    HTML: 828
  • SALIVA IRON AND FERRITIN LEVELS IN PATIENTS WITH THALASSEMIA AND IRON DEFICIENCY ANEMIA

    Duran Canatan, Sevgi Kosaci Akdeniz
    e2012051
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.051
    2808
    PDF: 1438
    HTML: 10860
  • MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS

    Sanjay Pandey, Sweta Pandey, Rahasya Mani Mishra, Renu Saxena
    e2012001
    2012-01-15
    https://doi.org/10.4084/mjhid.2012.001
    1442
    PDF: 861
    HTML: 1401
    Table: 175
  • COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia

    Yousef Saeed Mohammad Abu Za’ror, Joseph Bagi Suleiman, Fatima Azzahra Delmani, Jehad Farouq Alhmoud, Amer Mohammad Ayasreh, Sarah Ihsan Al-wendawi, Maryam Azlan
    e2026046
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.046
    1
    PDF: 0
    HTML: 0
  • Late-onset male hypogonadism and fertility potential in thalassemia major patients: Two emerging issues

    Vincenzo De Sanctis
    e2015047
    2015-07-08
    https://doi.org/10.4084/mjhid.2015.047
    1734
    PDF: 905
    HTML: 771
  • PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT

    Lucia De Franceschi
    e2009024
    2009-12-26
    1026
    PDF: 638
    HTML: 11057
  • DETECTION OF ? THALASSEMIA CARRIERS BY RED CELL PARAMETERS OBTAINED FROM AUTOMATIC COUNTERS USING MATHEMATICAL FORMULAS

    Idit Lachover Roth, Boaz Lachover, Guy Koren, Carina Levin, Luci Zalman, Ariel Koren
    e2018008
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.008
    4690
    PDF: 1658
    HTML: 1043
  • PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON

    Abdel Badih El Ariss, Mohamad Younes, Jad Matar, Zeina Berjaoui
    e2016015
    2016-02-20
    https://doi.org/10.4084/mjhid.2016.015
    4031
    PDF: 972
    HTML: 19135
  • IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES

    R S Balgir
    e2014060
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.060
    1305
    PDF: 835
    HTML: 7908
    Untitled: 186
  • ECONOMIC EVALUATION OF CHELATION REGIMENS FOR ?--THALASSEMIA MAJOR: A SYSTEMATIC REVIEW

    Jialian Li
    e2019036
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.036
    1919
    PDF: 1406
    HTML: 205
  • Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

    Giuseppe Leone, Luigi Maria Larocca, Eligio Pizzigallo
    e2009001
    2009-06-22
    3265
    PDF: 565
    HTML: 631
  • THE FREQUENCY OF ADRENAL INSUFFICIENCY IN ADOLESCENTS AND YOUNG ADULTS WITH THALASSEMIA MAJOR VERSUS THALASSEMIA INTERMEDIA IN IRAN

    Sara Matin, Masoud Ghanei Jahromi, Zohreh Karemizadeh, Sezaneh Haghpanah, Vincenzo De Sanctis, Ashraf Soliman, Mehran Karimi
    e2015005
    2014-08-28
    https://doi.org/10.4084/mjhid.2015.005
    1964
    PDF: 1020
    HTML: 9528
1 - 44 of 44 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy